DuPont Nutrition & Health Research Study Demonstrates a Role for Nasal Microbiota in the Host Response to Viral Respiratory Infection

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read More Add to Saved list
  • Source:
    Targeted News Service: U.S. Business (USA), September 26, 2018 Businesses, 4pp
  • Additional Information
    • Abstract:
      KANTVIK, Finland, Sept. 26 -- DuPont issued the following news release: A collaborative clinical study between DuPont Nutrition & Health, the University of Virginia and 4Pharma Ltd indicates that nasal microbiota may influence the viral load, host innate immune response and clinical symptoms during rhinovirus infection. The DuPont Microbiome Venture and Global Health & Nutrition Science teams have worked in collaboration with the University of Virginia and 4Pharma Ltd in an experimental rhinovirus challenge to understand the role of nasal microbiota clusters and their association with inflammatory response, viral load and symptom severity...